Drugsters Back On Top

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


What the press refers to as “tweaks” in the new version of health care legislation would appear to hand Big Pharma a sizeable victory, allowing the companies to extend the lifetimes of brand name drugs by selling them at discounted prices within the Medicare drug plan. This is portrayed as a magnanimous gesture by the profitable pharmaceutical makers. And to help the poor guys out a little and lessen the strain on their stockholders’ pocketbooks, the government apparently will come in to pay the companies some of the dough they lose in providing the discounts. Another way of putting this is that it seems the discounts aren’t really discounts at all. In the world of congressional smoke and mirrors, they’ve miraculously become a subsidy.

Government policy ought to push less expensive generic drugs into the marketplace. Mandating their preferred use by Medicare would be one small step in that direction. Generally speaking, the brand-name drugs should be eliminated when their patents run out. The proposed legislation apparently will have the effect of lengthening the company monopoly on brand names, thereby assuring higher, not lower prices.

Although somewhat confusing, this article from the New York Times may help you get a feel for what’s going on.

Bottom line: cost control is sacrificed market monopoly.

We've never been very good at being conservative.

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal.

This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

payment methods

We've never been very good at being conservative.

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal.

This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate